↓ Skip to main content

Early switching to ofatumumab avoids a rebound effect after natalizumab cessation in multiple sclerosis patients

Overview of attention for article published in Multiple Sclerosis Journal – Experimental, Translational and Clinical, September 2026

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

twitter
11 X users
bluesky
1 Bluesky user

Readers on

mendeley
1 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Early switching to ofatumumab avoids a rebound effect after natalizumab cessation in multiple sclerosis patients
Published in
Multiple Sclerosis Journal – Experimental, Translational and Clinical, September 2026
DOI 10.1177/20552173261487860
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 October 2026.
All research outputs
#6,518,817
of 34,567,073 outputs
Outputs from Multiple Sclerosis Journal – Experimental, Translational and Clinical
#139
of 535 outputs
Outputs of similar age
#33,090
of 290,826 outputs
Outputs of similar age from Multiple Sclerosis Journal – Experimental, Translational and Clinical
#2
of 15 outputs
Altmetric has tracked 34,567,073 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 535 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.6. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 290,826 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.